Effect of sodium channel blocker, pilsicainide hydrochloride, on net inward current of atrial myocytes in thyroid hormone toxicosis rats

Thyroid

Volumn 15, Issue 7, 2005, Pages 653-659

  Yamakawa, Munesada ^a   Sunagawa, Masanori ^a   Shimabukuro, Michio ^a   Higa, Namio ^a   Takasu, Nobuyuki ^a   Kosugi, Tadayoshi ^a  

^a UNIVERSITY OF THE RYUKYUS   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

LEVOTHYROXINE; PILSICAINIDE; SODIUM CHANNEL BLOCKING AGENT;

ACTION POTENTIAL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ELECTROCARDIOGRAM; HEART ARRHYTHMIA; HEART RATE; HEART REPOLARIZATION; INTOXICATION; MALE; NONHUMAN; P WAVE; PERITONEAL CAVITY; PRIORITY JOURNAL; QRS COMPLEX; QT INTERVAL; RAT; RAT STRAIN; RR INTERVAL;

ACTION POTENTIALS; ANIMALS; ARRHYTHMIA; ELECTROCARDIOGRAPHY; HEART ATRIA; LIDOCAINE; MALE; MYOCYTES, CARDIAC; RATS; RATS, SPRAGUE-DAWLEY; SODIUM; SODIUM CHANNEL BLOCKERS; THYROTOXICOSIS; THYROXINE;

EID: 23644432646     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.2005.15.653     Document Type: Article

References (23)

1. Terazawa T, Suzuki M, Goto T, Kato R, Hayashi H, Ito A, Isikawa S, Sotobata I 1991 Suppressive effect of SUN1165 on supraventricular tachycardia. Am Heart J 121:1437-1444.
2. Ino T, Atarashi H, Kuruma A, Onodera T, Saitoh H, Hayakawa H 1998 Electrophysiologic and hemodynamic effects of a single oral dose of pilsicainide hydrochloride, a new class 1c antiarrhythmic agent. J Cardiovasc Pharmacol 31:157-164.
3. Matsuo K, Kumagai K, Annoura M, Ideishi M, Arakawa K 1998 Mechanism of antiarrhythmic effects of class Ic drugs in paroxysmal atrial fibrillation in man. Cardiology 89:119-123.
4. Atarashi H, Inoue H, Hiejima K, Hayakawa H 1996 Conversion of recent-onset Atrial Fibrillation by a single oral dose of Pilsicainide (Pilsicainide Suppression Trial on atrial fibrillation). The PSTAF Investigators. Am J Cardiol 78: 694-697.
5. Forfar JC, Caldwell GC 1985 Hyperthyroid heart disease. Clin Endocrinol Metab 14:491-508.
6. von Olshausen K, Bischoff S, Kahaly G, Mohr-Kahaly S, Erbel R, Beyer J, Meyer J 1989 Cardiac arrhythmias and heart rate in hyperthyroidism. Am J Cardiol 63:930-933.
7. Klein I, Ojamaa K 2001 Thyroid hormone and the cardiovascular system. N Engl J Med 344:501-509.
8. Shimizu T, Koide S, Noh JY, Sugino K, Ito K, Nakazawa H 2002 Hyperthyroidism and the management of atrial fibrillation. Thyroid 12:489-493.
9. Asahi T, Shimabukuro M, Oshiro Y, Yoshida H, Takasu N 2001 Cilazapril prevents cardiac hypertrophy and postischemic myocardial dysfunction in hyperthyroid rats. Thyroid 11:1009-1015.
10. Oshiro Y, Shimabukuro M, Takasu N, Asahi T, Komiya, I, Yoshida H 2001 Triiodothyronine concomitantly inhibits calcium overload and postischemic myocardial stunning in diabetic rats. Life Sci 69:1907-1918.
11. + channel in rat arterial myocytes. Eur J Pharmacol 333:249-259.
12. + channel in rat ventricular cells. J Pharmacol Exp Ther 283:375-383.
13. 2+ current through activation of protein kinase A in cultured vascular smooth muscle cells. J Vasc Res 35:303-309.
14. Sunagawa M, Yamakawa M, Shimabukuro M, Higa N, Takasu N, Kosugi T 2005 Electrophysiologic characteristics on atrial myocytes of L-thyroxine-treated rats. Thyroid 15:3-11.
15. Sutovsky I, Katoh T, Takayama H, Ono T, Takano T 2003 Therapeutic monitoring of class I antiarrhythmic agents using high-resolution electrocardiography instead of blood samples. Circ J 67:195-198.
16. Dudley SC Jr, Baumgarten CM 1993 Bursting of cardiac sodium channels after acute exposure to 3,5,3′-triiodo-L-thyronine. Circ Res 73:301-313.
17. Macianskiene R, Viappiani S, Sipido KR, Mubagwa K 2003 Slowing of the inactivation of cardiac voltage-dependent sodium channels by the amiodarone derivative 2-methyl-3-(3,5-diiodo-4-carboxymethoxybenzyl)benzofuran (KB130015). J Pharmacol Exp Ther 304:130-138.
18. Yamashita T, Murakawa Y, Sezaki K, Hayami N, Inoue M, Fukui E, Omata M 1998 Uniqueness of pilsicainide in class Ic antiarrhythmics. Jpn Heart J 39:389-397.
19. Sperelakis N, Ramasamy L 2002 Modeling electric field transfer of excitation at cell junctions. IEEE Eng Med Biol Mag 21:130-143.
20. Sperelakis N 2002 An electric field mechanism for transmission of excitation between myocardial cells. Circ Res 91:985-987.
21. Sperelakis N, McConnell K 2002 Electric field interactions between closely abutting excitable cells. IEEE Eng Med Biol Mag 21:77-89.
22. Inomata N, Ishihara T 1988 Mechanism of inhibition by SUN 1165, a new Na channel blocking antiarrhythmic agent, of cardiac glycoside-induced triggered activity. Eur J Pharmacol 145:313-322.
23. Sun ZQ, Ojamaa K, Nakamura TY, Artman M, Klein I, Coetzee WA 2001 Thyroid hormone increases pacemaker activity in rat neonatal atrial myocytes. J Mol Cell Cardiol 33:811-824.